Consensus Virtual Screening Identified [1,2,4]Triazolo[1,5‐ b ]isoquinolines As MELK Inhibitor Chemotypes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Consensus Virtual Screening Identified [1,2,4]Triazolo[1,5‐ b ]isoquinolines As MELK Inhibitor Chemotypes

Published:2021-10-19 Issue:2 Volume:17 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Rácz Anita¹²^ORCID,Palkó Roberta²³^ORCID,Csányi Dorottya²,Riedl Zsuzsanna²,Bajusz Dávid²^ORCID,Keserű György M.²^ORCID

Affiliation:

1. Plasma Chemistry Research Group Research Centre for Natural Sciences Magyar tudósok krt. 2 1117 Budapest Hungary

2. Medicinal Chemistry Research Group Research Centre for Natural Sciences Magyar tudósok krt. 2 1117 Budapest Hungary

3. Present affiliation: Organocatalysis Research Group Research Centre for Natural Sciences Magyar tudósok krt. 2 1117 Budapest Hungary

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202100569

Reference50 articles.

1. New member of the Snf1/AMPK kinase family,Melk, is expressed in the mouse egg and preimplantation embryo

2. Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers

3. Resistance of colorectal cancer cells to radiation and 5-FU is associated with MELK expression

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural classification of MELK inhibitors and prospects for the treatment of tumor resistance: A review;Biomedicine & Pharmacotherapy;2022-12

2. Maximizing the integration of virtual and experimental screening in hit discovery;Expert Opinion on Drug Discovery;2022-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3